MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 104 filers reported holding MAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,741,343 | -31.0% | 1,840,174 | +1.5% | 0.00% | – |
| Q2 2023 | $8,318,797 | -6.3% | 1,812,374 | +1.0% | 0.00% | -100.0% |
| Q1 2023 | $8,881,038 | -54.6% | 1,794,149 | -49.9% | 0.00% | 0.0% |
| Q4 2022 | $19,563,912 | +72.3% | 3,583,134 | +105.2% | 0.00% | 0.0% |
| Q3 2022 | $11,352,000 | +54.2% | 1,746,509 | +12.2% | 0.00% | – |
| Q2 2022 | $7,363,000 | -32.6% | 1,556,695 | -0.4% | 0.00% | -100.0% |
| Q1 2022 | $10,924,000 | -18.2% | 1,562,760 | +19.2% | 0.00% | 0.0% |
| Q4 2021 | $13,355,000 | +1096.7% | 1,310,559 | +1334.2% | 0.00% | – |
| Q3 2021 | $1,116,000 | – | 91,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
| Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
| Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
| Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
| RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
| Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
| Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
| Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
| First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
| Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |